SYSMEX CORP.UNSP.ADR 1/2 (0YX0) - Total Assets
Based on the latest financial reports, SYSMEX CORP.UNSP.ADR 1/2 (0YX0) holds total assets worth €669.41 Billion EUR (≈ $782.61 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See SYSMEX CORP.UNSP.ADR 1/2 net assets for net asset value and shareholders' equity analysis.
SYSMEX CORP.UNSP.ADR 1/2 - Total Assets Trend (2022–2025)
This chart illustrates how SYSMEX CORP.UNSP.ADR 1/2's total assets have evolved over time, based on quarterly financial data. Check 0YX0 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
SYSMEX CORP.UNSP.ADR 1/2 - Asset Composition Analysis
Current Asset Composition (March 2025)
SYSMEX CORP.UNSP.ADR 1/2's total assets of €669.41 Billion consist of 54.8% current assets and 45.2% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 13.5% |
| Accounts Receivable | €163.01 Billion | 24.5% |
| Inventory | €81.81 Billion | 12.3% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €92.15 Billion | 13.9% |
| Goodwill | €14.21 Billion | 2.1% |
Asset Composition Trend (2022–2025)
This chart illustrates how SYSMEX CORP.UNSP.ADR 1/2's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of SYSMEX CORP.UNSP.ADR 1/2.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SYSMEX CORP.UNSP.ADR 1/2's current assets represent 54.8% of total assets in 2025, a decrease from 56.9% in 2022.
- Cash Position: Cash and equivalents constituted 13.5% of total assets in 2025, down from 15.3% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 15.0% of total assets, an increase from 13.0% in 2022.
- Asset Diversification: The largest asset category is accounts receivable at 24.5% of total assets.
SYSMEX CORP.UNSP.ADR 1/2 Competitors by Total Assets
Key competitors of SYSMEX CORP.UNSP.ADR 1/2 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Xiangyu Medical Co. Ltd. A
SHG:688626
|
China | CN¥3.27 Billion |
|
Xvivo Perfusion AB
ST:XVIVO
|
Sweden | Skr2.47 Billion |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
|
China | CN¥3.54 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Guangdong Transtek Medical Electronics Co Ltd
SHE:300562
|
China | CN¥1.42 Billion |
|
EBR Systems Inc
AU:EBR
|
Australia | AU$97.29 Million |
SYSMEX CORP.UNSP.ADR 1/2 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.34 | 3.19 | 3.19 |
| Quick Ratio | 2.49 | 2.42 | 2.42 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €251.46 Billion | €235.11 Billion | €235.11 Billion |
SYSMEX CORP.UNSP.ADR 1/2 - Advanced Valuation Insights
This section examines the relationship between SYSMEX CORP.UNSP.ADR 1/2's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.63 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 7.5% |
| Total Assets | €665.27 Billion |
| Market Capitalization | $4.70 Billion USD |
Valuation Analysis
Below Book Valuation: The market values SYSMEX CORP.UNSP.ADR 1/2's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: SYSMEX CORP.UNSP.ADR 1/2's assets grew by 7.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for SYSMEX CORP.UNSP.ADR 1/2 (2022–2025)
The table below shows the annual total assets of SYSMEX CORP.UNSP.ADR 1/2 from 2022 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | €665.27 Billion ≈ $777.77 Billion |
+7.49% |
| 2024-03-31 | €618.92 Billion ≈ $723.58 Billion |
+16.54% |
| 2023-03-31 | €531.07 Billion ≈ $620.88 Billion |
+9.79% |
| 2022-03-31 | €483.71 Billion ≈ $565.50 Billion |
-- |
About SYSMEX CORP.UNSP.ADR 1/2
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematol… Read more